Personal information

Verified email addresses

Verified email domains

Spain

Activities

Employment (3)

Immunostep S.L.: Salamanca, Castilla y León, ES

2023-07-24 to present | Investigador (Desarrollo)
Employment
Source: Self-asserted source
Óscar González López

Instituto de Investigación Biomédica de Salamanca: Salamanca, Castilla y León, ES

2020-07-23 to 2024-07-23 | Investigador predoctoral - Mastocitosis Sistémica (CANC11-Citómica)
Employment
Source: Self-asserted source
Óscar González López

Banco Nacional de ADN: Salamanca, Castilla y León, ES

2018-04-16 to 2020-07-23 | Técnico de Apoyo a la Investigación (Área de Nivel 3 de Contención Biológica (NCB3))
Employment
Source: Self-asserted source
Óscar González López

Education and qualifications (3)

International Federation of Biosafety Associations: Ottawa, Ontario, CA

2018-10-03 to present | Professional Certification in Biorisk Management
Qualification
Source: Self-asserted source
Óscar González López

Universidad de Granada: Granada, Andalucía, ES

2015-09-25 to 2016-09-15 | Máster en Investigación y Avances en Microbiología (Escuela Internacional de Posgrado)
Education
Source: Self-asserted source
Óscar González López

Universidad de Salamanca: Salamanca, Castilla y León, ES

2011-09-20 to 2015-07-13 | Grado en Biología (Facultad de Biología)
Education
Source: Self-asserted source
Óscar González López

Professional activities (2)

Asociación Española de Bioseguridad (AEBioS): Salamanca, Castilla y León, ES

2021-10-02 to 2023-10-04 | Tesorero (AEBioS)
Membership
Source: Self-asserted source
Óscar González López

Asociación Española de Bioseguridad (AEBioS): Salamanca, Castilla y León , ES

2018-10-06 to 2021-10-02 | Secretario
Membership
Source: Self-asserted source
Óscar González López

Funding (5)

Plataforma ISCIII Biomodelos y Biobancos

2024-01 to 2026-12 | Grant
Instituto de Salud Carlos III (Salamanca, ES)
GRANT_NUMBER: PT23/00086
Source: Self-asserted source
Óscar González López

Mastocitos Circulantes en casos de síndrome de activación mastocitaria y episodios graves de anafilaxia

2023-05 to 2024-05 | Grant
Asociación de Enfermos de Patologías Mitocondriales (Madrid, ES)
GRANT_NUMBER: FEM_MC_MCAS_2023
Source: Self-asserted source
Óscar González López

Diseño de un método de análisis diagnóstico en sangre periférica de pacientes con sospecha de patología mastocitaria y baja carga tumoral

2021-12 to 2024-12 | Grant
Ministerio de Ciencia, Innovación y Universidades (Salamanca, ES)
GRANT_NUMBER: PI22/01657
Source: Self-asserted source
Óscar González López

Modulación de la respuesta del sistema inmune en mastocitosis sistémica: papel del micromedioambiente celular y potencial asociación a la progresión clínica de la enfermedad

2021-01 to 2024-07 | Contract
Instituto de Salud Carlos III (Salamanca, ES)
GRANT_NUMBER: FI20/00116
Source: Self-asserted source
Óscar González López

Modulación de la respuesta del sistema inmune en mastocitosis sistémica: papel del micromedioambiente celular y potencial asociación a la progresión clínica de la enfermedad.

2020-07 to 2021-01 | Contract
Junta de Castilla y León (Salamanca, ES)
GRANT_NUMBER: PI19/01166
Source: Self-asserted source
Óscar González López

Works (7)

T‐cell immune profile in blood of systemic mastocytosis: Association with disease features

Allergy
2024-07 | Journal article | Author
Part of ISSN: 0105-4538
Part of ISSN: 1398-9995
Contributors: Alba Pérez Pons; Cristina Teodosio; María Jara‐Acevedo; Ana Henriques; Paula Navarro Navarro; Andrés C. García‐Montero; Iván Álvarez‐Twose; Quentin Lecrevisse; Rafael Fluxa; Laura Sánchez‐Muñoz et al.
Source: Self-asserted source
Óscar González López

Immune cell kinetics and antibody response in COVID‐19 patients with low‐count monoclonal B‐cell lymphocytosis

American Journal of Hematology
2023-12 | Journal article
Contributors: Guillermo Oliva‐Ariza; Blanca Fuentes‐Herrero; Quentin Lecrevisse; Cristina Carbonell; Alba Pérez‐Pons; Alba Torres‐Valle; Julio Pozo; José Ángel Martín‐Oterino; Óscar González‐López; Amparo López‐Bernús et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

Allergy
2023-05 | Journal article
Contributors: Paula Navarro‐Navarro; Iván Álvarez‐Twose; Alba Pérez‐Pons; Ana Henriques; Andrea Mayado; Andrés C. García‐Montero; Laura Sánchez‐Muñoz; Oscar González‐López; Almudena Matito; Carolina Caldas et al.
Source: check_circle
Crossref

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Blood
2023-01-19 | Journal article
Contributors: Guillermo Oliva-Ariza; Blanca Fuentes-Herrero; Cristina Carbonell; Quentin Lecrevisse; Alba Pérez-Pons; Alba Torres-Valle; Julio Pozo; José Ángel Martín-Oterino; Óscar González-López; Amparo López-Bernús et al.
Source: check_circle
Crossref

Altered innate immune profile in blood of systemic mastocytosis patients

Clinical and Translational Allergy
2022-06 | Journal article
Part of ISSN: 2045-7022
Part of ISSN: 2045-7022
Source: Self-asserted source
Óscar González López

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis

Cancers
2022-05-18 | Journal article
Contributors: Oscar González-López; Javier I. Muñoz-González; Alberto Orfao; Iván Álvarez-Twose; Andrés C. García-Montero
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Azoarcus anaerobius 1,3-Dihydroxybenzene (Resorcinol) Anaerobic Degradation Pathway Is Controlled by the Coordinated Activity of Two Enhancer-Binding Proteins

Applied and Environmental Microbiology
2017-05-01 | Journal article
Part of ISSN: 0099-2240
Part of ISSN: 1098-5336
Source: Self-asserted source
Óscar González López